Symptom validity testing (SVT) has become a major theme of contemporary neuropsychological research. However, many issues about the meaning and interpretation of SVT findings will require the best in research design and methods to more precisely characterize what SVT tasks measure and how SVT test findings are to be used in neuropsychological assessment. Major clinical and research issues are overviewed including the use of the ''effort'' term to connote validity of SVT performance, the use of cut-scores, the absence of lesion-localization studies in SVT research, neuropsychiatric status and SVT performance and the rigor of SVT research designs. Case studies that demonstrate critical issues involving SVT interpretation are presented. (JINS, 2012, 18, 632-642) 
Symptom validity testing (SVT) has emerged as a major theme of neuropsychological research and clinical practice. Neuropsychological assessment methods and procedures strive for and require the most valid and reliable techniques to assess cognitive and neurobehavioral functioning, to make neuropsychological inferences and diagnostic conclusions. From the beginnings of neuropsychology as a discipline, issues of test reliability and validity have always been a concern (Filskov & Boll, 1981; Lezak, 1976) . However, neuropsychology's initial focus was mostly on test development, standardization and the psychometric properties of a test and not independent measures of test validity. A variety of SVT methods are now available (Larrabee, 2007) . While contemporary neuropsychological test development has begun to more directly incorporate SVT indicators embedded within the primary neuropsychological instrument (Bender, Martin Garcia, & Barr, 2010; Miller et al., 2011; Powell, Locke, Smigielski, & McCrea, 2011) , traditional neuropsychological test construction and the vast majority of standardized tests currently in use do not. Current practice has been to use what are referred to as ''stand-alone'' SVT measures that are separately administered during the neuropsychological examination (Sollman & Berry, 2011) . SVT performance is then used to infer validity or lack thereof for the battery of all neuropsychological tests administered during that test session.
The growth in SVT research has been exponential. Using the search words ''symptom validity testing'' in a National Library of Medicine literature search yielded only one study before 1980, five articles during the 1980s, but hundreds thereafter. SVT research of the last decade has led to important practice conclusions as follows: (1) professional societies endorse SVT use (Bush et al., 2005; Heilbronner, Sweet, Morgan, Larrabee, & Millis, 2009 ), (2) passing a SVT infers valid performance, (3) SVT measures have good face validity as cognitive measures, all have components that are easy for healthy controls and even for the majority of neurological patients to pass with few or no errors, and (4) groups that perform below established cut-score levels on a SVT generally exhibit lower neuropsychological test scores. This last observation has been interpreted as demonstrating that SVT performance taps a dimension of effort to perform, where SVT ''failure'' reflects non-neurological factors that reduce neuropsychological test scores and invalidates findings (West, Curtis, Greve, & Bianchini, 2011) . On forced-choice SVTs, the statistical improbability of below chance performance implicates malingering (the examinee knows the correct answer but selects the incorrect to feign impairment).
A quote from Millis (2009) captures the importance of why neuropsychology must address the validity of test performance:
All cognitive tests require that patients give their best effort (italics added) when completing them. Furthermore, cognitive tests do not directly measure cognition: they measure behavior from which we make inferences about cognition. People are able to consciously alter or modify their behavior, including their behavior when performing cognitive tests. Ostensibly poor or ''impaired'' test scores will be obtained if an examinee withholds effort (e.g., reacting slowly to reaction time tests). There are many reasons why people may fail to give best effort on cognitive testing: financial compensation for personal injury; disability payments; avoiding or escaping formal duty or responsibilities (e.g., prison, military, or public service, or family support payments or other financial obligations); or psychosocial reinforcement for assuming the sick role (Slick, Sherman, & Iverson, 1999) . ''y. Clinical observation alone cannot reliably differentiate examinees giving best effort from those who are not.'' (Millis & Volinsky, 2001 , p. 2409 This short review examines key SVT concepts and the ''effort'' term as used in neuropsychology. ''Effort'' seems to capture a clinical descriptive of patient test performance that, at first blush, seems straightforward enough. However, effort also has neurobiological underpinnings, a perspective often overlooked in SVT research and clinical application. Furthermore, does the term effort suggest intention, such as ''genuine effort'' -the patient is trying their best? Or if maximum ''effort'' is not being applied to test performance or exhibited by the patient, when does it reflect performance that may not be trustworthy? What is meant by effort?
''EFFORT'' -ITS MULTIPLE MEANINGS
In the SVT literature when the ''effort'' term is linked with other nouns, verbs, and/or adjectives such statements appear to infer or explain a patient's mental state, including motivation. For example it is common to see commentaries in the SVT literature indicating something about ''cognitive effort,'' ''mental effort,'' ''insufficient effort,'' ''poor effort,'' ''invalid effort,'' or even ''faked effort.'' Some of these terms suggest that neuropsychological techniques, and in particular the SVT measure itself, are capable of inferring intent? Can they (see discussion by Dressing, Widder, & Foerster, 2010) ? There are additional terms often used to describe SVT findings including response bias, disingenuous, dissimulation, non-credible, malingered, or non-or sub-optimal, further complicating SVT nomenclature. There is no agreed upon consensus definition within neuropsychology of what effort means.
Below Cut-Score SVT Performance and Neuropsychological Test Findings: THE ISSUE An exemplary SVT study has been done by Locke, Smigielski, Powell, and Stevens (2008) . This study is singled out for this review because it was performed at an academic medical center (many SVT studies are based on practitioners' clinical cases), had institutional review board (IRB) approval (most SVT studies do not), examined non-forensic (no case was in litigation although some cases had already been judged disabled and were receiving compensation), and was based on consecutive clinical referrals (independently diagnosed with some type of acquired brain injury [ABI] before the neuropsychological assessment) with all patients being seen for treatment recommendations and/or actual treatment. Figure 1 shows the distribution of pass/fail SVT scores where 21.8% performed below the SVT cut-point [pass Z 45/50 items correct on Trial 2 of the Test of Memory Malingering (TOMM), Tombaugh, 1996] , which Locke et al. defined as Fig. 1 . The distribution of Test of Memory Malingering (TOMM) scores that were above (green) the cut-point of 45 compared to those who performed below (blue-red). Note the bi-modal distribution of those who failed, compared to the peaked performance of 50/50 correct by those who pass. Below chance responding is the most accepted SVT feature indicative of malingering. As indicated by the shading of blue coloration emerging into red, as performance approaches chance, that likely reflects considerable likelihood of malingering. However, recalling that all of these patients had some form of ABI, those in blue, are much closer to the cut-point, raising the question of whether their neurological condition may contribute to their SVT performance. constituting a group of ABI patients exhibiting ''sub-optimal'' effort. Of greater significance for neuropsychology is that the subjects in the failed SVT group, while being matched on all other demographic factors, performed worse and statistically lower across most (but not all) neuropsychological test measures.
As seen in Figure 1 , the modal response is a perfect or near perfect TOMM score of 50/50 correct, presumably reflective of valid test performance. The fact that all subjects had ABI previously and independently diagnosed before the SVT being administered, and most performed without error, is a testament to the ease of performing an SVT. For those who scored below the cut-point and thereby ''failed'' the SVT measure, a distinct bi-modal distribution emerges. One group, shown in red (see Figure 1 ), hovers around chance (clearly an invalid performance) but the majority of others who fail, as shown in blue, hover much closer to, but obviously below, the SVT cut-point.
For the purposes of this review, the distinctly abovechance but below cut-score performing group will be labeled the ''Near-Pass'' SVT group. It is with this group where the clinician/researcher is confronted with Type I and II statistical errors when attempting to address validity issues of neuropsychological test findings. All current SVT methods acknowledge that certain neurological conditions may influence SVT performance, but few provide much in the way of guidelines as to how this problem should be addressed.
Type II Error and the Patient With a ''Near-Pass SVT'' performance 1 Two cases among many seen in our University-based neuropsychology program are representative of the problems with classifying neuropsychological test performance as invalid in the ''Near-Pass'' SVT performing patient. Figure 2 depicts the post-temporal lobectomy MRI in a patient with intractable epilepsy who underwent a partial right hippocampectomy. Pre-surgery he passes all SVT measures but post-surgery passes some but not others. Figure 3 shows abnormal medial temporal damage in a patient with herpes simplex encephalitis who fails SVT measures. In both cases, SVT failure is not below chance, both patients have distinct, bona fide and unequivocal structural damage to critical brain regions involved in memory. Is not their SVT performance a reflection of the underlying damage and its disruption of memory performance? If a neuropsychologist interpreted these test data as invalid because of ''failed'' SVT performance, is that not ignoring the obvious and committing a Type II error? So when is ''failed'' SVT performance just a reflection of underlying neuropathology? For example, cognitive impairment associated with Alzheimer's disease is sufficient to impair SVT performance resulting in below recommended cut-score levels and therefore constituting 1 It is impossible to discuss SVT measures without discussing some by name. This should not be considered as any type of endorsement or critique of the SVT mentioned. SVT inclusion of named tests in this review occurred merely on the basis of the research being cited.
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E.D. Bigler a SVT failure (Merten, Bossink, & Schmand, 2007) . However, in such a circumstance impaired neuropsychological performance and the low SVT score are both thought to reflect genuinely impaired cognitive ability.
No Systematic Study Lesion/Localization Studies of SVT performance
Neuropsychological assessment has a long tradition of examining lesion effects (or lack thereof) on neuropsychological test performance (Cipolotti & Warrington, 1995) . There are no systematic studies of lesion effects on SVT performance. Despite the assumption of minimal requirements to perform a SVT task, episodic memory is being tapped where functional neuroimaging studies demonstrate expected medial temporal, cingulate and parietofrontal attentional network activation during SVT performance (Allen, Bigler, Larsen, GoodrichHunsaker, & Hopkins, 2007; Browndyke et al., 2008; Larsen, Allen, Bigler, Goodrich-Hunsaker, & Hopkins, 2010 
Illness Behavior and Cognitive Performance
In non-litigating neurological and neuropsychiatric clinical populations, 15 to 30% or higher SVT failure rates have been reported (Williams, 2011) . Does this mean invalid neuropsychological test data occurs in up to one-third of all patients seen for neuropsychological assessment based on not passing an externally administered SVT? Are these patients malingering?
What is the role of SVT performance in rendering differential diagnoses involving malingering, somatoform disorder and other neuropsychiatric conditions? Figure 4 from Metternich, Schmidtke, and Hull (2009) 
Diagnosis Threat and SVT Performance
The ''diagnosis threat'' literature clearly demonstrates both experimentally and clinically that performance expectations influence actual cognitive test performance and the perceived influence of symptoms on cognitive test results (Ozen & Fernandes, 2011; Suhr & Gunstad, 2005) . Likewise, placebo research on cognitive performance plainly demonstrates the influential role that expectations have on symptom generation and test performance (Pollo & Benedetti, 2009 Effort or Ability?
If SVT performance required minimal to no cognitive effort, then experimental paradigms using cognitive load as a 
Design Issues in SVT Research
The review to this point has raised several interpretative questions that occur in Near-Pass SVT subjects. The answer to these questions requires better designed SVT studies that address ambiguities of past SVT findings. Williams (2011) points out the necessity of some ''messy'' SVT research designs due to the impossibility of getting genuine malingerers to volunteer for standardization studies. Standardization studies have had to rely on simulator studies and clinical samples; mostly ones of convenience and mostly forensic samples.
Circular reasoning, tautology and SVT research
If one uses SVT performance as the only index of effort and then concludes that SVT failure is a sign of ''poor effort,'' yet there are no other independent measures of what may be test behavior compliance or willingness to engage, process, and perform, or even malinger, then is this not a tautological argument? In such studies the only classifier defining poor effort is the SVT performance itself. While such studies often classify subjects by secondary gain identifiers (litigation, disability determination, etc.), such identifiers are not direct measures of effort, only of secondary gain. Tautology also involves the unnecessary repetitive use of different words with the same meaning. The list of terms being used interchangeably with SVT and effort include response bias, invalid or failed performance, symptom amplification, performance exaggeration, underperformance or distortion, symptom embellishment, disingenuous, sub-optimal, poor effort, non-credible, faked and malingered. It is not uncommon to see statements like -''Failed SVT performance was associated with invalid neuropsychological test performance that was deemed non-credible due to sub-optimal effort.'' The tautological problems with such a statement should be obvious.
Rigor of SVT studies
Class I and II level research as endorsed by the National Institutes of Health (NIH) and all major medical societies involves independently conducted investigations that have some external review and monitoring where investigators are independent of the outcome at all levels of the investigation (Edlund, Gronseth, So, & Franklin, 2004) . The best Class I and II investigations are those where a priori consensus diagnostic standards are in place that are independent of any outcome measure, data collected prospectively and independently from those in charge of their analysis, where clinicians involved in diagnostic decision making are independent of those who analyze the data, and who are also blinded. In Class I or II investigations, clinicians and data managers cannot also be the statisticians. Explicitly different roles at all levels of data acquisition, tabulation, analysis, and report writing increases the likelihood of unbiased findings. Institutional based investigations require human subjects review, consent, and IRB approval.
Few current SVT studies meet Class I or II level research or are subject to IRB approval. SVT studies that come from clinical practitioners in private practice not affiliated with an institution do not fall under any external review process whatsoever. Important investigational research comes from clinicians in private practice but rarely does this research meet a Class I or II standard.
IS THERE A NEUROBIOLOGY OF DRIVE, EFFORT, MOTIVATION, AND ATTENTION?
Much of the discussion up to this point has focused on cognitive elements of SVT performance but there is also a behavioral dimension that centers on the neurobiology of drive, effort, and motivation (Sarter, Gehring, & Kozak, 2006) . Patients with frontotemporolimbic damage may be apathetic with problems sustaining drive and goal-directed behaviors (Lezak, Howieson & Loring, 2004) . Apathy is a common consequence of traumatic brain injury (TBI; Marin & Wilkosz, 2005) . What happens during neuropsychological assessment of the patient with neurogenic drive and motivation problems? The following test scores were obtained in a patient approximately one year post-TBI who the family described as unmotivated; neuroimaging demonstrated extensive bi-frontal and right parietal encephalomalacia and generalized atrophy: TOMM: Trial 1 5 45/50; Trial 2 5 50/50; Rey 15-Item: 10/15; Word Memory Test (WMT): IR (immediate recognition) 5 78%; DR (delayed recognition) 5 85%; CNS (consistency response) 5 78%). The 45/ 50 on TOMM Trial 1 represents a pass, but is right at the cutscore with a perfect 50/50 on Trial 2 representing a pass by all standards. The Rey 15-Item performance represents a pass (although a borderline score by some standards); however, a 78% correct on the WMT IR and CNS Scales represents a ''failure'' by WMT standards. How does brain damage to motivational and attentional networks affect SVT performance and should patients with obvious structural lesions be evaluated by different cut-score standards?
Which Test to Use?
There are now numerous SVT measures available for use in general neuropsychological practice (Grant & Adams, 2009; 636 E.D. Bigler Lezak, Howieson, & Loring, 2004; Mitrushina, Boone, Razani, & D'Elia, 2005; Strauss, Sherman, & Spreen, 2006; Tate, 2010) and potentially even more in a forensic setting (Boone, 2007; Larrabee, 2007; THE PROBLEM WITH CUT SCORES Dwyer (1996) reviewed the methods of cut-score development concluding that cut-scores (a) always entail judgment; (b) inherently result in some misclassification, (c) impose artificial ''pass/fail'' dichotomies and (d) no ''true'' cut scores exist (p. 360). Given Dwyer's comments, should cut scores be adjusted or customized to specific clinical conditions? Kirkwood and Kirk (2010) in a university-based assessment clinic evaluated 193 consecutively referred children with mild TBI. This study had IRB approval and these investigators examined both the TOMM and Medical Symptom Validity Test (MSVT; Green, 2004) . Using their terminology, Kirkwood and Kirk (2010) found 17% of the sample to exhibit ''suboptimal effort.'' Only one failure was thought to be influenced by litigation. They also attempted to identify other potential sources for SVT failure, including impulsivity, distractibility during testing, pre-injury neuropsychiatric diagnosis and potential effects of reading disability. This study unmistakably demonstrates the complexities and potential issues in a clinical sample that may lead to sub-optimal performance. In the Merten et al. (2007) study mentioned earlier that examined bona fide neurological patients with and without clinically obvious symptoms only 15/48 (31%) passed all SVTs. Only 1/24 (4%) of those with clinically obvious cognitive symptoms was able to pass all SVTs. These authors conclude that the ''y. Results clearly show that many of these bona fide patients fail on most SVTs. Had the recommended cutoffs been applied rigorously without taking the clinical picture into consideration, these patients would have been incorrectly classified as exerting insufficient effort.'' (p. 314). Donders and Strong (2011) attempted to replicate a logistic regression method that had been developed by Wolfe et al. (2010) to identify embedded effort indicators on the California Verbal Learning Test (CVLT). They not only applied the logistic regression method of Wolfe et al. but also used an externally administered SVT. However, the limits of interrelationship and inter-test agreement between actual test performances, embedded indicators of effort and the external SVT led them to conclude that this method was not ready for clinical application.
These studies simply underscore the difficulties of what needs to be addressed and accounted for in the neuropsychological application of current SVT technology. Similarly, Powell et al. (2011) show that supposed markers of suboptimal effort using the Trail Making Test, also have limited predictive ability; again demonstrating the problem of disentangling true neuropsychological performance from associated elements of effort, drive, motivation, and attention when attempting to use embedded methods that were not explicitly designed to simultaneously assess validity.
Cut-scores are a necessary part of contemporary neuropsychological testing as they provide a method for classification but cut-scores are best used in the context of guidelines, rather than a dichotomous defining point for presence or absence of a deficit (Strauss et al., 2006) .
False Memory and Dissociative Reactions
Mental health issues as they relate to ''false memory'' have been the topic of considerable controversy in clinical, research, and legal settings (Loftus & Davis, 2006) . Interestingly, even an animal model of false memory has been developed (McTighe, Cowell, Winters, Bussey, & Saksida, 2010) . Are some SVT failures by neurological or neuropsychiatric patients generated by ''false memories''? For example, cognitive neuroscience often examines how confident a subject is in their response, when assessing false memory (Moritz & Woodward, 2006) . No SVT studies to date have tackled this dimension.
Does Failed SVT Always Equate With Invalid Performance for All Neuropsychological Measures?
In the Locke et al. (2008) investigation not all neuropsychological test scores were significantly suppressed in the failed SVT group. The Category Test and two of the three Wisconsin Card Sorting measures did not differ between the group that ''passed'' the SVT and the group that ''failed'' nor did scores on the Beck Depression and Anxiety scales. Whitney, Shepard, Mariner, Mossbarger, and Herman (2010) found that Wechsler Test of Adult Reading (WTAR) scores were no different between those with passed or failed SVT performance suggesting that WTAR findings remain ''robust even in the face of suboptimal effort' ' (p. 196) . Does this mean valid neuropsychological test findings occur with some tests even in the presence of SVT ''failure''?
SVT Deception
Is the SVT measure infallible? DenBoer and Hall (2007) have shown that simulators can be ''taught'' how to detect SVT tasks and pass them and go on to fail the more formal neuropsychological measures (see also Rüsseler, Brett, Klaue, Sailer, & Munte, 2008) . If the SVT task can be faked how would the clinician and/or researcher know?
CONCLUSIONS
SVT findings may offer important information about neuropsychological test performance, but if an oversimplified view Symptom validity testing assessmentof SVT-test behavior dichotomizes neuropsychological performance as either valid (above cut-score) or invalid (below cut-score), clinically important Type I and II errors are unavoidable. As shown in this review, patients with legitimate neurological and/or neuropsychiatric conditions fail SVTs for likely neurogenic factors. There can be no debate that issues of poor effort and secondary gain may have such a profound effect as to completely invalidate neuropsychological test findings rendering them uninterruptable (see Stevens, Friedel, Mehren, & Merten, 2008) . However, considerably more SVT research is needed to address the issues raised in this review.
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